A Study Assessing the Safety, Efficacy, and Optimum Dosage of K-161 in Subjects With Moderate to Severe Dry Eye Disease
NCT04084483
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
238
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Disease
Interventions
DRUG:
K-161
OTHER:
Placebo (Vehicle)
Sponsor
Kowa Research Institute, Inc.